Form 4 for NATR NATURES SUNSHINE PRODUCTS INC
Accepted 2025-06-27 00:00:00 ET · period of report 2025-06-27 · accession 0001140361-25-023976 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-27 | 2025-06-27 | NATR | Fosun Pharma USA Inc. | 10% | S - Sale | $11.46 | -2.85M | 0 | -100% | -$32.71M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-27 | S | D | 2,854,607 | $11.46 | 0 | I by Fosun Pharma USA Inc. | — | — | (F2) Fosun Pharma USA Inc. is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |